NEW YORK -- The Consumer Product Safety Commission's intent to require information from certificates of compliance to be filed in ACE next year is alarming brokers, according to Erin Williamson, vice president of customs brokerage at GEODIS USA.
Trade attorneys continue to wait and wonder what kind of tariff changes will come next year, with one observer using a tariff slide that said "Tariff Armageddon."
NEW YORK -- Tyler Beckelman, a Commerce deputy assistant secretary who also sits on the interagency Forced Labor Enforcement Task Force, told a garment industry audience that the Biden administration still intends to issue a notice of proposed rulemaking on de minimis "before we all turn into pumpkins on Jan. 20."
The following lawsuits were filed at the Court of International Trade during the week of Nov. 4-10:
International Trade Today is providing readers with the top stories from last week in case they were missed. All articles can be found by searching on the titles or by clicking on the hyperlinked reference number.
A past trade staffer from the Senate Finance Committee said that if Congress wanted to write tariffs into law in order to use that revenue as a partial pay-for in tax cut extensions, those tariffs would likely wait until January 2026, as that's when the tax laws would take effect.
In less than three months, President Donald Trump will be back in the White House, after a campaign during which he floated 10% or 20% tariffs on all countries except China, which would be hit with an additional 60 percentage points on top of current tariffs.
The following lawsuits were filed at the Court of International Trade during the week of Oct. 28 - Nov. 3:
The Court of International Trade rejected importer Retractable Technologies' bids for a temporary restraining order and preliminary injunction stopping the collection of Section 301 duties on its needles and syringes. However, in a decision made public Nov. 4, Judge Claire Kelly did stop liquidation of Retractable's entries during the course of the company's suit, which challenges the legality of a Section 301 rate hike on needles and syringes.
Four Democratic senators are asking the Treasury Department to end de minimis treatment for all e-commerce shipments, arguing that the regulations under development to restrict de minimis would not go far enough to curtail fentanyl smuggling.